Tracheostomy

1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Renovion
RenovionNC - Chapel Hill
1 program
1
ARINA-1Phase 11 trial
Active Trials
NCT05658029WithdrawnEst. Sep 2023
Atos Medical
Atos MedicalSweden - Horby
2 programs
TW speaking valve/HMEN/A1 trial
TrachPhone HMEN/A1 trial
Active Trials
NCT01976819CompletedEst. Apr 2014
NCT06487104Enrolling By InvitationEst. Apr 2026
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
TracheostomyN/A1 trial
Active Trials
NCT07404592CompletedEst. Oct 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
RenovionARINA-1
City TherapeuticsTracheostomy
Atos MedicalTrachPhone HME
Atos MedicalTW speaking valve/HME

Clinical Trials (4)

An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a Tracheostomy

Start: May 2023Est. completion: Sep 2023
Phase 1Withdrawn

Tracheostomy Practices in Adult Intensive Care Units: A Multicentre Study in Izmir

Start: Sep 2025Est. completion: Oct 2025
N/ACompleted

Use of TrachPhone in Tracheostomized Patients

Start: Feb 2025Est. completion: Apr 2026
N/AEnrolling By Invitation
NCT01976819Atos MedicalTW speaking valve/HME

Clinical Assessment of New Speaking Valve With Heat and Moisture Exchanger (HME) for Tracheotomized Patients

Start: Oct 2013Est. completion: Apr 2014
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space